New York Life Investment Management’s Viking Therapeutics VKTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-11,097	Closed	-$447K	–	849
2024 Q4	$447K	Sell	11,097 -881	-7%	-$35.5K	﹤0.01%	788
2024 Q3	$758K	Buy	11,978 +672	+6%	+$42.5K	0.01%	753
2024 Q2	$599K	Buy	+11,306	New	+$599K	0.01%	789